BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24124017)

  • 1. Engineering stem cell fate with biochemical and biomechanical properties of microcarriers.
    Sart S; Agathos SN; Li Y
    Biotechnol Prog; 2013; 29(6):1354-66. PubMed ID: 24124017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mesenchymal stem cell actin organization on conventional microcarriers for proliferation and differentiation in stirred bioreactors.
    Sart S; Errachid A; Schneider YJ; Agathos SN
    J Tissue Eng Regen Med; 2013 Jul; 7(7):537-51. PubMed ID: 22383400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-Scale Expansion and Differentiation of Mesenchymal Stem Cells in Microcarrier-Based Stirred Bioreactors.
    Sart S; Agathos SN
    Methods Mol Biol; 2016; 1502():87-102. PubMed ID: 26892015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue.
    Carmelo JG; Fernandes-Platzgummer A; Diogo MM; da Silva CL; Cabral JM
    Biotechnol J; 2015 Aug; 10(8):1235-47. PubMed ID: 26136376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scalable ex vivo expansion of human mesenchymal stem/stromal cells in microcarrier-based stirred culture systems.
    Carmelo JG; Fernandes-Platzgummer A; Cabral JM; da Silva CL
    Methods Mol Biol; 2015; 1283():147-59. PubMed ID: 25063496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting cell aggregation during mesenchymal stem cell expansion on microcarriers.
    Ferrari C; Balandras F; Guedon E; Olmos E; Chevalot I; Marc A
    Biotechnol Prog; 2012; 28(3):780-7. PubMed ID: 22374883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction.
    Chen AK; Reuveny S; Oh SK
    Biotechnol Adv; 2013 Nov; 31(7):1032-46. PubMed ID: 23531528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspension culture on microcarriers and as aggregates enables expansion and differentiation of pluripotent stem cells (PSCs).
    Vallabhaneni H; Shah T; Shah P; Hursh DA
    Cytotherapy; 2023 Sep; 25(9):993-1005. PubMed ID: 37256241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors.
    Rafiq QA; Coopman K; Nienow AW; Hewitt CJ
    Biotechnol J; 2016 Mar; 11(4):473-86. PubMed ID: 26632496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells.
    Frauenschuh S; Reichmann E; Ibold Y; Goetz PM; Sittinger M; Ringe J
    Biotechnol Prog; 2007; 23(1):187-93. PubMed ID: 17269687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of Human Mesenchymal Stem Cells in a Microcarrier Bioreactor.
    Tsai AC; Ma T
    Methods Mol Biol; 2016; 1502():77-86. PubMed ID: 27032950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
    Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
    J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors.
    Krawetz R; Taiani JT; Liu S; Meng G; Li X; Kallos MS; Rancourt DE
    Tissue Eng Part C Methods; 2010 Aug; 16(4):573-82. PubMed ID: 19737071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.
    Fernandes-Platzgummer A; Carmelo JG; da Silva CL; Cabral JM
    Methods Mol Biol; 2016; 1416():375-88. PubMed ID: 27236684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and cost.
    Haskell A; White BP; Rogers RE; Goebel E; Lopez MG; Syvyk AE; de Oliveira DA; Barreda HA; Benton J; Benavides OR; Dalal S; Bae E; Zhang Y; Maitland K; Nikolov Z; Liu F; Lee RH; Kaunas R; Gregory CA
    Cytotherapy; 2024 Apr; 26(4):372-382. PubMed ID: 38363250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.
    Sousa MF; Silva MM; Giroux D; Hashimura Y; Wesselschmidt R; Lee B; Roldão A; Carrondo MJ; Alves PM; Serra M
    Biotechnol Prog; 2015; 31(6):1600-12. PubMed ID: 26289142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale production of stem cells and their derivatives.
    Zweigerdt R
    Adv Biochem Eng Biotechnol; 2009; 114():201-35. PubMed ID: 19513633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells.
    de Soure AM; Fernandes-Platzgummer A; da Silva CL; Cabral JM
    J Biotechnol; 2016 Oct; 236():88-109. PubMed ID: 27527397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering.
    Wu R; Liu G; Bharadwaj S; Zhang Y
    Methods Mol Biol; 2013; 1001():65-80. PubMed ID: 23494421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Three-Dimensional Dynamic Regulation and In Situ Characterization of Single Stem Cell Phenotype Using Microfluidics.
    Sart S; Agathos SN
    Mol Biotechnol; 2018 Nov; 60(11):843-861. PubMed ID: 30196389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.